FILE PHOTO: Pascal Soriot, CEO of AstraZeneca PLC arrives at Portcullis House to attend a parliamentary business and enterprise committee hearing on the future of AstraZeneca, in central London, May 13, 2014. REUTERS/Toby Melville
FILE PHOTO: Pascal Soriot, CEO of AstraZeneca PLC arrives at Portcullis House to attend a parliamentary business and enterprise committee hearing on the future of AstraZeneca, in central London, May 13, 2014. REUTERS/Toby Melville